What is Stateam?
Stateam operates as a specialized service provider within the healthcare and clinical research industries, offering a comprehensive suite of services. These include biostatistics, data analytics, statistical programming, quality assurance, regulatory affairs, and pharmacovigilance. The company's core mission is to deliver expert consulting and support throughout the entire clinical development spectrum, with a particular emphasis on strategic consulting and regulatory submission strategies. Stateam aims to provide tangible value to its clients by navigating complex regulatory landscapes and ensuring high-quality service delivery tailored to specific client needs.
How much funding has Stateam raised?
Stateam has raised a total of $25K across 1 funding round:
Debt
$25K
Debt (2021): $25K with participation from PPP
Key Investors in Stateam
PPP
Public-Private Partnership
What's next for Stateam?
With the recent substantial expansion capital, Stateam is poised to accelerate its growth trajectory. The company is likely to invest in scaling its operational capacity, enhancing its technological infrastructure, and potentially expanding its service offerings or geographic reach. This strategic financing will enable Stateam to further solidify its market position, deepen its client relationships, and pursue new opportunities in the dynamic biopharmaceutical and healthcare research markets. The focus on regulatory affairs and clinical development suggests a strategic push towards supporting more complex and lengthy research projects.
See full Stateam company page
